EverHint – SMA20 × SMA50 Crossover Signals for Feb 02, 2026 – Healthcare Leads with 7 Setups
What This Signal Is (Quick)
This strategy detects fresh crossovers between the 20-day simple moving average (SMA20) and the 50-day simple moving average (SMA50):
-
Buy Signal (SMA20_x_SMA50_Buy) - "Golden Cross": SMA(20) crosses above SMA(50) on today's close
- Short-term momentum (20 days) exceeds medium-term trend (50 days)
- Bullish trend confirmation with high reliability
- Ideal for medium-term trend following (4-12 week holding periods)
-
Sell Signal (SMA20_x_SMA50_Sell) - "Death Cross": SMA(20) crosses below SMA(50) on today's close
- Short-term momentum weakens below medium-term trend
- Bearish trend confirmation
- Can signal exit points or trend reversal alerts
Key Characteristics:
- Uses two SMAs (both simple moving averages) for maximum stability
- Most stable strategy - fewer signals but highest quality (fewer whipsaws)
- Better suited for medium-term trends with confirmed momentum
- Lower risk entries compared to faster EMA-based strategies
Key Criteria:
-
Buy: SMA20 crosses above SMA50
-
Sell: SMA20 crosses below SMA50
-
Minimum ADV: $40M (liquidity filter)
-
Earnings buffer: 7 days pre/post earnings
-
Fresh crossover: Detected on today's close
Holding Period: 2-6 weeks
Risk Level: Medium
How We Ranked Today
Ranked by RSI (lower RSI = more oversold for buy signals)
📊 SMA20 × SMA50 Crossover Signals (Top 15 of 28 total)
Ranked by rsi14:
| Rank | Ticker | Company | Sector | Last ($) | RSI14 | Insider Net | Days → Earnings | Est EPS | Mkt Cap ($B) |
|---|---|---|---|---|---|---|---|---|---|
| 1 | RELX | RELX PLC PLC | Industrials | 35.53 | 1.2 | — | 10 | $1.80 | 66.3 |
| 2 | ARES | Ares Management Corpor... | Financial Services | 146.47 | 9.2 | $-33.1M | 2 | $9.78 | 48.1 |
| 3 | OWL | Blue Owl Capital Inc. | Financial Services | 13.42 | 23.4 | — | 3 | $1.48 | 21.0 |
| 4 | GIB | CGI Inc. | Technology | 86.62 | 23.9 | — | 85 | $10.72 | 19.1 |
| 5 | APO | Apollo Global Manageme... | Financial Services | 133.19 | 24.1 | — | 87 | $13.30 | 77.3 |
| 6 | CZR | Caesars Entertainment,... | Consumer Cyclical | 20.59 | 24.6 | — | 84 | $3.09 | 4.3 |
| 7 | SBET | SharpLink Gaming, Inc. | Consumer Cyclical | 7.79 | 29.8 | — | 39 | $0.12 | 1.2 |
| 8 | MGNI | Magnite, Inc. | Communication Services | 14.06 | 30.0 | $-203K | 23 | $0.47 | 2.0 |
| 9 | IRT | Independence Realty Tr... | Real Estate | 16.42 | 34.7 | — | 85 | $0.35 | 3.9 |
| 10 | MUR | Murphy Oil Corporation | Energy | 29.61 | 39.7 | — | — | $4.25 | 4.2 |
| 11 | BIIB | Biogen Inc. | Healthcare | 179.09 | 42.2 | — | 86 | $17.03 | 26.3 |
| 12 | EQH | Equitable Holdings, Inc. | Financial Services | 46.75 | 42.4 | — | 84 | $10.69 | 14.0 |
| 13 | TLN | Talen Energy Corporation | Utilities | 340.80 | 43.2 | — | 24 | $39.21 | 15.6 |
| 14 | LAD | Lithia Motors, Inc. | Consumer Cyclical | 327.66 | 47.2 | — | 78 | $60.44 | 7.9 |
| 15 | CYTK | Cytokinetics, Incorpor... | Healthcare | 65.16 | 51.5 | $-3.0M | 24 | $0.98 | 8.0 |
Field Notes
Sector concentration: Healthcare (7), Financial Services (5), Consumer Cyclical (4)
Insider selling: ARES (Ares Management Corporation, $-33.1M), TERN (Terns Pharmaceuticals, Inc., $-3.5M), CYTK (Cytokinetics, Incorporated, $-3.0M)
Near-term earnings: ARES (Ares Management Corporation), COR (Cencora, Inc.), OWL (Blue Owl Capital Inc.), PFGC (Performance Food Group Company) report within 7 days. Higher volatility risk.
Data coverage: 25.0% insider, 7.1% congressional (2 older/1y), 96.4% earnings, 100.0% analyst, 28.6% news
Congressional Activity
MASI (Masimo Corporation) 🔴 Bearish (1y)
- 1 sale by 1 member
- Top seller: Hou. Kevin Hern (OK) - 1 transaction ($15,001 - $50,000)
AEP (American Electric Power Company) ⚪ Neutral (1y)
- 2 total transactions: 1 purchases, 1 sales
- Top seller: Hou. David Taylor (OH) - 1 transaction ($1,001 - $15,000)
- Top buyer: Hou. Rick Larsen (WA) - 1 transaction ($1,001 - $15,000)
Recent Headlines
APO (Apollo Global Management, Inc.)
- Exclusive: Apollo to invest in Canada's largest fitness club operator The GoodLife Group (source)
- Apollo to Present at the UBS Financial Services Conference (source)
- Apollo Global Management (APO) to Release Earnings on Monday (source)
- 10-12% Yields Trading For Pennies On The Dollar (source)
- Bank of New York Mellon Corp Acquires 48,053 Shares of Apollo Global Management Inc. $APO (source)
- Apollo Provides €900 Million Refinancing for Pan-European Logistics and Industrial Portfolio Owned by Cerberus and Arrow Capital Partners (source)
ARES (Ares Management Corporation)
- Elara Caring Secures New Strategic Investment from Ares and DaVita (source)
- Here's Why Ares Management (ARES) is a Strong Growth Stock (source)
- Why Investors Need to Take Advantage of These 2 Finance Stocks Now (source)
- 10-12% Yields Trading For Pennies On The Dollar (source)
- Ares Management (ARES) Earnings Expected to Grow: Should You Buy? (source)
- Top 5 Private Equity Holding Companies: Publicly Traded PE Titans (source)
- Ares Leads $1.6 Billion Debt Financing to Support Suave Brands and Elida Beauty Merger to Create Evermark (source)
- Ares Management Corporation to Present at the Bank of America Securities 2026 Financial Services Conference (source)
- Makarora Completes Acquisition of Plymouth Industrial REIT for $2.1 Billion (source)
BIIB (Biogen Inc.)
- New York State Common Retirement Fund Buys 3,220 Shares of Biogen Inc. $BIIB (source)
- Great Lakes Advisors LLC Takes $1.33 Million Position in Biogen Inc. $BIIB (source)
- Biogen Inc. (NASDAQ:BIIB) Given Consensus Recommendation of “Hold” by Analysts (source)
- Privium Fund Management B.V. Boosts Stake in Biogen Inc. $BIIB (source)
- Analysts Estimate Biogen Inc. (BIIB) to Report a Decline in Earnings: What to Look Out for (source)
- Biogen's Autoimmune Disease Candidate Gets FDA's Breakthrough Status (source)
- Biogen's Litifilimab Receives FDA Breakthrough Therapy Designation for Cutaneous Lupus Erythematosus, a Disease With No Targeted Treatment Options (source)
RELX (RELX PLC PLC)
- LexisNexis Risk Solutions Launches LexisNexis IDVerse for Insurance to Help U.S. Insurance Companies Combat AI-Driven Threats and Better Protect Their Customers (source)
- Down 6.7% in 4 Weeks, Here's Why You Should You Buy the Dip in RELX (RELX) (source)
- LexisNexis Risk Solutions Achieves FedRAMP "In Process" Status, Advancing Secure Cloud Capabilities for U.S. Government Agencies (source)
SBET (SharpLink Gaming, Inc.)
- Is SharpLink Gaming Stock a Buy or Sell After Apeiron Capital Sold Its Stake Valued at $23 Million? (source)
- Here Are Thursday’s Top Wall Street Analyst Research Calls: Agnico Eagle, First Solar, Fortinet, General Motors, NVR, StoneCo, Werner Enterprises, Zillow, and More (source)
- Exclusive: Michael Saylor Pioneered Crypto Treasury Firms, But This Ethereum-Centric Company CEO Says Their Model Unlocks More Potential: Here's Why (source)
Market Context
Broad market indices advanced on the session, with the Dow Jones leading gains at +1.29%, followed by the Nasdaq (+0.95%) and S&P 500 (+0.86%). This uniform upside reflects a clear bullish trend and elevated risk appetite, creating a favorable environment for SMA20/SMA50 strategies. These moving average crossovers thrive in trending markets, where short-term momentum (SMA20) aligns with intermediate trends (SMA50), generating reliable buy signals amid sustained buying pressure. The 28 total signals suggest broad participation, amplifying potential for follow-through in uptrends.
The VIX plunged 17.54% to 16.45, signaling sharply reduced volatility and muted intraday swings. Lower volatility supports SMA strategies by minimizing whipsaws—false crossovers caused by noise—allowing trends to develop more predictably. Traders can pursue signals with tighter stops and higher conviction, as diminished fear reduces the likelihood of abrupt reversals disrupting the 20/50-day alignments.
With Healthcare as the top sector for signals, this points to sector rotation toward resilient areas even in a risk-on climate. Broad index strength implies defensive sectors like Healthcare may be catching up or leading, offering diversified opportunities within the SMA framework. Risk appetite remains robust, but monitoring for overextension in laggard sectors could refine signal selectivity.
Vlad's Take (EverHint)
Today's signals: Strong sector concentration in Healthcare (7 signals) suggests sector-specific rotation. 7 signals showing insider selling warrant caution.
Sharing Call-to-Action
📈 Enjoying the updates? Liking, sharing, or subscribing helps bring this analysis to a wider audience.
Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.
This is not financial advice. Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/